Executives at even the most bullish government contractors have been forced to reset growth expectations.
They have explained the dire federal budget situation to shareholders, private equity investors and financial analysts. They have negotiated with commercial bankers and other lenders to shore up their cash. And they’ve met with anxious employees to calm their staff’s nerves.
While these are uncomfortable discussions, let’s not feel too sorry for government integrators, technology providers, defense contractors and consulting firms. They’re far from snakebit.
That’s because the customers they serve – federal and state/local government agencies – will always have need and dollars to spend. There will be cycles and periods of diminished budgets, yet the market is constant.
The collaboration will allow the partners to globally expand financial advisory services and cross-border transactions for life sciences and biopharmaceutical client companies Boston & Shanghai – September 14, 2023. Outcome Capital, a specialized life science advisory and investment banking firm, and YAFO Capital, a Shanghai-based boutique investment banking and advisory firm, announced that the companies […]Read More
Outcome Capital Life Science Market Pulse August 2023 Click to view our LifeSciences Pulse NewsletterDownload